Carbon dioxide laser microsurgery for early glottic carcinoma.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 16730529.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To define the oncologic efficacy of transoral endoscopic CO2 laser surgery in early glottic carcinoma. A retrospective study of 103 patients with glottic carcinoma (14 Tis, 68 pT1a, 14 pT1b, and 7 pT2) treated from October 1993 to June 2001. Surgical treatment included endoscopic CO2 laser cordectomies according to the classification of the European Laryngological Society. According to the Kaplan-Meier method, the probability of remaining free of local recurrence 5 years after primary surgery alone was 100% for the Tis, 96.05% for the T1, and 100% for the T2. Local control at 5 years after exclusive CO2 laser salvage surgery was 98.03%. The probability of remaining free of local recurrence 5 years after any type of salvage surgery was 100%. Laryngeal preservation was achieved in 100% of the cases. According to the present series, endoscopic CO2 laser surgery is an effective treatment for early glottic cancer. C-4.
Medical subject headings
- Carcinoma, Squamous Cell
- Glottis
- Laryngeal Neoplasms
- Laser Therapy
- Microsurgery